Merck KGaA, Darmstadt, Germany, Announces € 20 Million OLED Manufacturing Expansion in Korea and China
- OLED manufacturing capacities will be expanded at the Pyeongtaek and Shanghai sites
- Additional OLED sublimation units will help meet customer demand in the growing OLED market of Asia
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a € 20 million expansion of its OLED (organic light-emitting diode) manufacturing capacity at its sites in Pyeongtaek, Korea and Shanghai, China. Additional sublimation units will be built to help meet customer demand in the growing OLED market. With the investment, Merck KGaA, Darmstadt, Germany will further increase its local OLED production footprint in Korea and establish OLED production capacity in China. The enhanced local manufacturing capacities will strengthen the company’s position as key supplier of high-purity OLED materials for panel makers in Asia. With its Performance Materials business sector, Merck KGaA, Darmstadt, Germany is a leading player in the electronic materials market and OLED materials are one of the defined investment focus areas for future growth.
“OLED technology is the fastest growing display technology enabling next-generation displays”, said Kai Beckmann, Member of the Executive Board of Merck KGaA, Darmstadt, Germany and CEO Performance Materials. “By expanding our local manufacturing capacities, we’re well positioned to efficiently produce and deliver higher volumes of OLED materials. This investment underscores our commitment to creating an agile supply chain for our customers in Asia.”
The € 20 million investment will be used to build a new modular production system that facilitates the installation of additional sublimation units in line with market requirements. Sublimation processes are key to ensure the highest quality of OLED materials. The purity of OLED materials is one of the most important factors affecting the performance and lifetime of OLED devices.
As new form factors enabled by OLED technology – such as foldable and rollable displays – continue to penetrate the market, Merck KGaA, Darmstadt, Germany is expanding its OLED manufacturing capacities in Asia to meet the increasing demand for high-purity OLED materials.
With research activities dating back three decades as well as early investments in OLED manufacturing capacities, Merck KGaA, Darmstadt, Germany is well positioned as a leading global material supplier of this technology. In 2010, the company established an OLED Research Center at its global headquarters in Darmstadt, Germany. In 2015, Merck KGaA, Darmstadt, Germany inaugurated an OLED Application Center (OAC) in Pyeongtaek, Korea. In 2016, the company opened an additional production plant for OLED materials in Darmstadt, Germany. Since 2018, Merck KGaA, Darmstadt, Germany has also been supporting Chinese customers in its OLED Technology Center (OTC) in Shanghai, China.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck KGaA, Darmstadt, Germany, generated sales of € 16.2 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.